Lung Cancer News and Research

Latest Lung Cancer News and Research

Data from Amgen's XGEVA and Vectibix studies to be presented at EMCC 2011

Amgen announced today that data from XGEVA (denosumab) and Vectibix (panitumumab) studies will be presented at the 2011 European Multidisciplinary Cancer Congress, Sept. 23 - 27, 2011, in Stockholm, Sweden.

23 Sep 2011

University of Kentucky receives Department of Defense grant for lung cancer study

The University of Kentucky's Dr. Susanne Arnold and colleagues were awarded a grant by the Department of Defense to study potential environmental reasons for the high lung cancer rates in Eastern Kentucky.

23 Sep 2011

Cambridge Heart enters agreement with EO Medical for MTWA technology

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.

22 Sep 2011

New Poll: 9 out of 10 Ontarians would support an investment in lung health

According to a new Leger Marketing poll conducted for the Ontario Lung Association, 9 out of 10 of Ontarians would support the Ontario government investing in lung health today if it would save future healthcare spending.

22 Sep 2011

Virginia G. Piper, TGen and Scottsdale Healthcare begin AP26113 Phase 1 study in NSCLC

Patients at Virginia G. Piper Cancer Center Clinical Trials are the first in the nation to participate in a clinical trial to determine the safety, tolerability and preliminary activity of an investigational drug that targets cell-signaling proteins associated with the most common form of lung cancer, as well as other forms of cancer such as lymphomas and neuroblastoma.

22 Sep 2011

NEJM publishes Boehringer Ingelheim's BIBF 1120 phase II trial on IPF

Boehringer Ingelheim's investigational tyrosine kinase inhibitor (TKI) BIBF 1120 demonstrated a positive trend in reducing lung function decline in patients with idiopathic pulmonary fibrosis (IPF), according to phase II clinical trial results published today online in the New England Journal of Medicine.

22 Sep 2011

African Americans more likely than Caucasians to develop and die from lung cancer

Lung cancer, the leading cause of cancer death in the U.S., takes a particularly heavy toll on African Americans. Despite their lower smoking rates, African Americans are more likely than Caucasians to develop and die from lung cancer.

21 Sep 2011

Study assesses impact of ethnicity on second-line treatment of non-small cell lung cancer

Racial and ethnic minorities are more likely to develop cancer and die from it than the general U.S. population. However, as the next generation of cancer medicines are being evaluated, only 17 percent of clinical trial participants are, in fact, minorities.

21 Sep 2011

Enrollment commences in Boehringer Ingelheim's TOviTO Phase III combination trial for COPD

Boehringer Ingelheim today announced enrolment has commenced in its TOviTO Phase III clinical trial program. It will investigate tiotropium plus olodaterol in a once-daily fixed-dose combination for the treatment of chronic obstructive pulmonary disease.

21 Sep 2011

Preclinical studies shows EmPAC more effective than Taxol

Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™, its nanoparticle reformulation of paclitaxel, in the August issue of the Journal of Nanoscience and Nanotechnology. The publication highlights data demonstrating improved safety and efficacy of EmPAC™ versus Taxol®, the generic formulation of paclitaxel and one of the most widely prescribed chemotherapies. EmPAC™ is a nanoemulsion formulation of Paclitaxel and is the lead product candidate of Cornerstone’s proprietary Emulsiphan™ cancer selective delivery nanotechnology platform. Taxol®, an injectable formulation of Paclitaxel, is currently used to treat a variety of cancers, including ovarian carcinomas, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi’s sarcoma.

19 Sep 2011

Roxon plans to propagate tough stands on tobacco packaging

Health Minister Nicola Roxon plans to encourage other countries to follow Australia's push for plain-packaged tobacco at a major United Nations summit on chronic diseases today.

19 Sep 2011

ESMO honors three medical oncologists for cancer care and research

The European Society for Medical Oncology (ESMO) has honored three of Europe's leading medical oncologists with prestigious awards recognizing their achievements in clinical care and research.

19 Sep 2011

Good absorption of calcium linked to prostate cancer

A study by epidemiologists at Wake Forest Baptist Medical Center and colleagues suggests that a high intake of calcium causes prostate cancer among African-American men who are genetically good absorbers of the mineral.

17 Sep 2011

Nation's battle against tobacco use reduces smoking rates, lung cancer: CDC report

The following is a statement of Matthew L. Myers President, Campaign for Tobacco-Free Kids: A new report published today by the U.S. Centers for Disease Control and Prevention provides powerful and concrete evidence that the nation's battle against tobacco use has not only driven down smoking rates, but is also saving lives by reducing lung cancer, the number one cancer killer in the United States.

16 Sep 2011

New nanopore sensor can lead to early detection of lung cancer

When lung cancer strikes, it often spreads silently into more advanced stages before being detected. In a new article published in Nature Nanotechnology, biological engineers and medical scientists at the University of Missouri reveal how their discovery could provide a much earlier warning signal.

16 Sep 2011

Polyplus-transfection appoints ten additional biologists and chemists to support multiple pre-clinical studies

Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, today celebrates ten years of continuous growth.

15 Sep 2011

Celecoxib inhibits GSK3 enzyme in lung cancer cells

Several clinical studies have shown that taking the anti-inflammatory drug celecoxib can reduce the risk of developing polyps that lead to colon cancers, at the cost of increasing the risk of heart disease. But what if this tradeoff was not necessary?

14 Sep 2011

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

Pfizer Oncology announced today that data evaluating crizotinib in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC), as well as data from Pfizer's renal cell carcinoma (RCC) portfolio on axitinib, an investigational compound, and SUTENT(sunitinib malate) will be presented at the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden, September 23 - 27, 2011.

14 Sep 2011

New drug combination may treat two aggressive cancers

Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings are published in Cancer Cell on September 13, 2011.

13 Sep 2011

Researchers identify new type of potential anticancer drug

Researchers at Emory University School of Medicine have identified a new type of potential anticancer drug. The compound, named FOBISIN, targets 14-3-3 proteins, important for the runaway growth of cancer cells.

13 Sep 2011

Lung Cancer News and Research

Latest Lung Cancer News and Research

Data from Amgen's XGEVA and Vectibix studies to be presented at EMCC 2011

University of Kentucky receives Department of Defense grant for lung cancer study

Cambridge Heart enters agreement with EO Medical for MTWA technology

New Poll: 9 out of 10 Ontarians would support an investment in lung health

Virginia G. Piper, TGen and Scottsdale Healthcare begin AP26113 Phase 1 study in NSCLC

NEJM publishes Boehringer Ingelheim's BIBF 1120 phase II trial on IPF

African Americans more likely than Caucasians to develop and die from lung cancer

Study assesses impact of ethnicity on second-line treatment of non-small cell lung cancer

Enrollment commences in Boehringer Ingelheim's TOviTO Phase III combination trial for COPD

Preclinical studies shows EmPAC more effective than Taxol

Roxon plans to propagate tough stands on tobacco packaging

ESMO honors three medical oncologists for cancer care and research

Good absorption of calcium linked to prostate cancer

Nation's battle against tobacco use reduces smoking rates, lung cancer: CDC report

New nanopore sensor can lead to early detection of lung cancer

Polyplus-transfection appoints ten additional biologists and chemists to support multiple pre-clinical studies

Celecoxib inhibits GSK3 enzyme in lung cancer cells

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

New drug combination may treat two aggressive cancers

Researchers identify new type of potential anticancer drug

The ultimate guide to lung research tools and protocols eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in